scholarly journals Initial Experience in Endovenous Laser Ablation (EVLA) of Varicose Veins Due to Small Saphenous Vein Reflux

2007 ◽  
Vol 33 (5) ◽  
pp. 614-618 ◽  
Author(s):  
N.S. Theivacumar ◽  
R.J. Beale ◽  
A.I.D. Mavor ◽  
M.J. Gough
2015 ◽  
Vol 30 (7) ◽  
pp. 500-500

The clinical significance of below-knee great saphenous vein reflux following endovenous laser ablation of above-knee great saphenous vein, by NS Theivacumar, RJ Darwood, D Dellagrammaticas, AID Mavor, MJ Gough, Phlebology DOI:10.1258/phleb.2008.008004, published February 2009; 24 (1): 17–20 . The authors would like to note the following correction to their article: One of the co-authors’ names was misspelled; it appears as “Dellegrammaticas”; however, it should be spelt “Dellagrammaticas”.


2009 ◽  
Vol 50 (5) ◽  
pp. 1106-1113 ◽  
Author(s):  
Laura van Groenendael ◽  
J. Adam van der Vliet ◽  
Lizel Flinkenflögel ◽  
Elisabeth A. Roovers ◽  
Steven M.M. van Sterkenburg ◽  
...  

2020 ◽  
pp. 026835552093974
Author(s):  
Boutros Karam ◽  
Moustafa Moussally ◽  
Hussein Nassar ◽  
Karim Ataya ◽  
Rola Jaafar ◽  
...  

Introduction Endovenous laser ablation (EVLA) has become the gold standard for the treatment of saphenous vein reflux. We report the long-term clinical and ultrasound results of EVLA. Methods This study is a retrospective review of patients who underwent EVLA of saphenous vein over four years. Clinical results were assessed using venous clinical severity score (VCSS), and ultrasound results were classified according to Bush classification. Results Over a median follow-up time of 4.4 years, 168 EVLA-treated patients showed a drop in VCSS from 4.38 to 1.39. Ultrasound results of 140 treated great saphenous veins showed that 64% had one or more cause of recurrence. The presence of neovascularization correlated well with the lack of improvement of VCSS. Conclusion EVLA resulted in drop in VCSS from 4.38 to 1.39. Among 140 treated great saphenous veins, reflux in the anterior accessory saphenous vein was the primary cause (23.5%) of recurrence.


2020 ◽  
Vol 8 ◽  
pp. 2050313X2092642
Author(s):  
Satoshi Watanabe ◽  
Takafumi Tsuji ◽  
Shinya Fujita ◽  
Soji Nishio ◽  
Eisho Kyo

Recurrent varicose veins are considered to be caused by the recurrence of reflux but rarely may be secondary to other pathologies. A 39-year-old man complained of right lower leg skin pigmentation, pain and fatigue for several years. Duplex ultrasound revealed that the great saphenous vein diameter at the saphenofemoral junction level was 7.7 cm, and at the knee medial level was 14.4 cm. The reflux time at the proximal great saphenousvein level was 1.85 s. Endovenous laser ablation for dilated and refluxed great saphenous vein was performed. However, 1 year later, the symptoms recurred. Duplex ultrasound suspected abnormal arterial flow from the right superficial femoral artery to the recanalized segment of previously ablated great saphenous vein and anterior accessory saphenous vein. One month later, despite the successful re-endovenous laser ablation, the symptoms recurred. Computed tomography angiography showed three fistulous vessels from superficial femoral artery to anterior accessory saphenous vein. Combined treatments with endovenous laser ablation and coil embolization was performed. Ultimately, the fistulas were obliterated and the patient remained free of symptoms. Varicose veins due to the fistulas from superficial femoral artery are rare and difficult to diagnose but can be entirely treated with the percutaneous approach.


Vascular ◽  
2013 ◽  
Vol 21 (6) ◽  
pp. 375-379 ◽  
Author(s):  
Firat H Altin ◽  
Baris Kutas ◽  
Tevfik Gunes ◽  
Selim Aydin ◽  
Bortecin Eygi

Different systems for delivering tumescent solution exist in endovenous laser ablation (EVLA). This study evaluated three different tumescent delivery systems in patients with primary varicose veins due to great saphenous vein reflux who were treated with EVLA. In this prospective non-randomized study, 60 patients with isolated GSV varicose veins were divided into three groups. All patients received EVLA treatment. Three different tumescent solution delivery systems were used. Systems consisted of a needle and a syringe in Group 1, a needle connected to an infusion bag system in Group 2 and a peristaltic infiltration pump in Group 3. Tumescent delivery durations were in Group 1: 6.56 SD 1.18 minutes, Group 2: 6.05 SD 2.19 minutes and Group 3: 5.19 SD 1.15 minutes ( P = 0.014). In the outcomes of the study there were no significant difference between groups. Although peristaltic pump systems might provide shorter tumescent delivery durations without hand fatigue, shorter duration does not have any practical importance (about 1 minute and also it is not cost-effective. For delivering tumescent solutions in EVLA procedures, there was no major superiority between systems.


Sign in / Sign up

Export Citation Format

Share Document